Cargando…

A CRISPR-Cas Cure for HIV/AIDS

Human immunodeficiency virus (HIV) infections and HIV-induced acquired immunodeficiency syndrome (AIDS) continue to represent a global health burden. There is currently no effective vaccine, nor any cure, for HIV infections; existing antiretroviral therapy can suppress viral replication, but only as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hussein, Mouraya, Molina, Mariano A., Berkhout, Ben, Herrera-Carrillo, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863116/ https://www.ncbi.nlm.nih.gov/pubmed/36675077 http://dx.doi.org/10.3390/ijms24021563

Ejemplares similares

Efficient CRISPR-Cas13d-Based Antiviral Strategy to Combat SARS-CoV-2
por: Hussein, Mouraya, et al.
Publicado: (2023)

A combinatorial CRISPR-Cas12a attack on HIV DNA
por: Fan, Minghui, et al.
Publicado: (2022)

Bone Marrow Gene Therapy for HIV/AIDS
por: Herrera-Carrillo, Elena, et al.
Publicado: (2015)

In Silico Prediction and Selection of Target Sequences in the SARS-CoV-2 RNA Genome for an Antiviral Attack
por: Hussein, Mouraya, et al.
Publicado: (2022)

The Impact of HIV-1 Genetic Diversity on CRISPR-Cas9 Antiviral Activity and Viral Escape
por: Darcis, Gilles, et al.
Publicado: (2019)

Extinction of all infectious HIV in cell culture by the CRISPR-Cas12a system with only a single crRNA
por: Gao, Zongliang, et al.
Publicado: (2020)

A Single H1 Promoter Can Drive Both Guide RNA and Endonuclease Expression in the CRISPR-Cas9 System
por: Gao, Zongliang, et al.
Publicado: (2018)

Elimination of infectious HIV DNA by CRISPR–Cas9
por: Das, Atze T, et al.
Publicado: (2019)

In-house ELISA protocols for capsid p24 detection of diverse HIV isolates
por: Molina, Mariano A., et al.
Publicado: (2023)

Improvement of the CRISPR-Cpf1 system with ribozyme-processed crRNA
por: Gao, Zongliang, et al.
Publicado: (2018)

CRISPR/Cas9: a double-edged sword when used to combat HIV infection
por: Liang, Chen, et al.
Publicado: (2016)

Immunotherapy and CRISPR Cas Systems: Potential Cure of COVID-19?
por: He, Xuesong, et al.
Publicado: (2022)

Recent Progress and Future Prospective in HBV Cure by CRISPR/Cas
por: Yang, Yu-Chan, et al.
Publicado: (2021)

CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape
por: Wang, Gang, et al.
Publicado: (2016)

CRISPR/Cas9 therapeutics: a cure for cancer and other genetic diseases
por: Khan, Faheem Ahmed, et al.
Publicado: (2016)

Targeting TRIM5α in HIV Cure Strategies for the CRISPR-Cas9 Era
por: Weatherley, Daryl Anne Victoria, et al.
Publicado: (2017)

CRISPR-Cas9 Dual-gRNA Attack Causes Mutation, Excision and Inversion of the HIV-1 Proviral DNA
por: Binda, Caroline S., et al.
Publicado: (2020)

Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies
por: Darcis, Gilles, et al.
Publicado: (2018)

Novel AgoshRNA molecules for silencing of the CCR5 co-receptor for HIV-1 infection
por: Herrera-Carrillo, Elena, et al.
Publicado: (2017)

Transient CRISPR-Cas Treatment Can Prevent Reactivation of HIV-1 Replication in a Latently Infected T-Cell Line
por: Liu, Ye, et al.
Publicado: (2021)

Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy
por: Xiao, Qiaoqiao, et al.
Publicado: (2019)

Stem cell transplantation in strategies for curing HIV/AIDS
por: Hütter, Gero
Publicado: (2016)

CRISPR/Cas9—A Promising Therapeutic Tool to Cure Blindness: Current Scenario and Future Prospects
por: Ahmad, Irshad
Publicado: (2022)

CRISPR/Cas9: a tool to eradicate HIV-1
por: Bhowmik, Ruchira, et al.
Publicado: (2022)

Novel Approaches Towards a Functional Cure of HIV/AIDS
por: Bailon, Lucia, et al.
Publicado: (2020)

A versatile one-step CRISPR-Cas9 based approach to plasmid-curing
por: Lauritsen, Ida, et al.
Publicado: (2017)

A CRISPR/Cas9 guidance RNA screen platform for HIV provirus disruption and HIV/AIDS gene therapy in astrocytes
por: Huang, Zaohua, et al.
Publicado: (2017)

Antiretroviral treatment, government policy and economy of HIV/AIDS in Brazil: is it time for HIV cure in the country?
por: Benzaken, Adele S., et al.
Publicado: (2019)

CRISPR-Cas in Streptococcus pyogenes
por: Le Rhun, Anaïs, et al.
Publicado: (2019)

CRISPR-Cas-Integrated LAMP
por: Atçeken, Nazente, et al.
Publicado: (2022)

Eradication of HIV and Cure of AIDS, Now and How?
por: Zhang, Jielin, et al.
Publicado: (2013)

The Potential Use of the CRISPR-Cas System for HIV-1 Gene Therapy
por: Sanches-da-Silva, Gabriela De Nardi, et al.
Publicado: (2019)

Dicer-independent processing of small RNA duplexes: mechanistic insights and applications
por: Herrera-Carrillo, Elena, et al.
Publicado: (2017)

SARS-CoV-2 Evolution: On the Sudden Appearance of the Omicron Variant
por: Berkhout, Ben, et al.
Publicado: (2022)

Updates on CRISPR-based gene editing in HIV-1/AIDS therapy
por: Zhang, Zhihao, et al.
Publicado: (2022)

Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems
por: Zhang, Fei, et al.
Publicado: (2019)

New insights on CRISPR/Cas9-based therapy for breast Cancer
por: Sabit, Hussein, et al.
Publicado: (2021)

Advances in CRISPR/Cas9
por: Zhu, Youmin
Publicado: (2022)

HIV infection detection using CRISPR/Cas systems: Present and future prospects
por: Deng, Bingpeng, et al.
Publicado: (2023)

CRISPR-Cas Genome Surgery in Ophthalmology
por: DiCarlo, James E., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7dja2o7d7l8itpck8vv40o0dha